Published in Proc Natl Acad Sci U S A on June 26, 2008
Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacol Ther (2010) 1.06
A differential role for neuropeptides in acute and chronic adaptive responses to alcohol: behavioural and genetic analysis in Caenorhabditis elegans. PLoS One (2010) 1.02
Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine. Genes Brain Behav (2010) 0.93
Corticotropin-releasing factor critical for zebrafish camouflage behavior is regulated by light and sensitive to ethanol. J Neurosci (2011) 0.82
Early life stress is a risk factor for excessive alcohol drinking and impulsivity in adults and is mediated via a CRF/GABAA mechanism. Stress (2016) 0.81
Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevance. Front Neuroendocrinol (2013) 0.80
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder. PLoS One (2016) 0.75
Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice. Basic Clin Neurosci (2015) 0.75
CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol (2004) 5.21
Addiction and the brain antireward system. Annu Rev Psychol (2008) 5.17
A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 3.16
Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res (2002) 3.11
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry (2006) 2.70
Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci (2002) 2.69
Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol (1989) 1.92
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol Biochem Behav (2004) 1.86
Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Brain Res Rev (1997) 1.61
Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc Natl Acad Sci U S A (1993) 1.40
Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med (1997) 1.21
Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism. Proc Natl Acad Sci U S A (2008) 1.10
A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology (1997) 1.07
Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res (1996) 1.07
Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res (1992) 0.99
Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res (1990) 0.98
Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res (1993) 0.89
Psychomotor stimulant sensitization: the corticotropin-releasing factor-steroid connection. Commentary on Wise and Leeb "Psychomotor-stimulant sensitization: a unitary phenomenon?" Behav Pharmacol (1993) 0.81
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
A role for brain stress systems in addiction. Neuron (2008) 4.71